Noradrénaline And NotP. Allain
List of bibliographic references
Number of relevant bibliographic references: 15.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000199 | M. Sabbar [France, Maroc] ; C. Delaville [France] ; P. De Deurwaerdere [France] ; A. Benazzouz [France] ; N. Lakhdar-Ghazal [Maroc] | LEAD INTOXICATION INDUCES NORADRENALINE DEPLETION, MOTOR NONMOTOR DISABILITIES, AND CHANGES IN THE FIRING PATTERN OF SUBTHALAMIC NUCLEUS NEURONS |
| 000222 | C. Delaville [France] ; S. Navailles [France] ; A. Benazzouz [France] | EFFECTS OF NORADRENALINE AND SEROTONIN DEPLETIONS ON THE NEURONAL ACTIVITY OF GLOBUS PALLIDUS AND SUBSTANTIA NIGRA PARS RETICULATA IN EXPERIMENTAL PARKINSONISM |
| 000417 | D. Devos [France] ; R. Bordet [France] ; L. Defebvre [France] | Hypothèses pharmacologiques et prise en charge thérapeutique des troubles de la marche de la maladie de Parkinson : Troubles de la marche |
| 000484 | Dawn M. Eagle [Royaume-Uni] ; Christelle Baunez [France] | Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition |
| 000501 | David Devos [France] ; L. Defebvre [France] ; R. Bordet [France] | Dopaminergic and non-dopaminergic pharmacological hypotheses for gait disorders in Parkinson's disease |
| 000685 | André Galinowski [France] ; May Ghossoub [France] ; Thomas Weber [France] | Les troubles anxieux dans la maladie de Parkinson |
| 000776 | David Devos [France] ; Kathy Dujardin [France] ; Isabelle Poirot [France] ; Caroline Moreau [France] ; Olivier Cottencin [France] ; Pierre Thomas [France] ; Alain Destée [France] ; Regis Bordet [France] ; Luc Defebvre [France] | Comparison of Desipramine and Citalopram Treatments for Depression in Parkinson's Disease : A Double-Blind, Randomized, Placebo-Controlled Study |
| 000843 | Charlotte Laloux [France] ; Philippe Derambure [France] ; Jean-Marie Jacquesson [France] ; Régis Bordet [France] ; Alain Destée [France] ; Christelle Monaca [France] | The effects of serotoninergic, noradrenergic, cholinergic and dopaminergic drugs on vigilance states in MPTP-treated mice |
| 000974 | Jean-Pierre Wolf [France] ; Malika Bouhaddi [France] ; Francis Louisy [France] ; Andrei Mikehiev [France] ; Laurent Mourot [France] ; Sylvie Cappelle [France] ; Fabrice Vuillier [France] ; Pierre Andre [France] ; Lucien Rumbach [France] ; Jacques Regnard [France] | Side-effects of l-dopa on venous tone in Parkinson's disease : a leg-weighing assessment |
| 000C24 | Marc R. Marien [France] ; Francis C. Colpaert [France] ; Alan C. Rosenquist [France, États-Unis] | Noradrenergic mechanisms in neurodegenerative diseases: a theory |
| 000C40 | M. Bouhaddi [France] ; F. Vuillier [France] ; J. O. Forkat [France] ; S. Cappelle [France] ; M. T. Henriet [France] ; L. Rumbach [France] ; J. Regnard [France] | Impaired cardiovascular autonomic control in newly and long-term-treated patients with Parkinson's disease: involvement of L-dopa therapy |
| 000D82 | S. Baker [France] ; E. Moyse [France] ; F. Jourdan [France] ; F. Colpaert [France] ; J. C. Martel [France] ; M. Marien [France] | Effects of the α2-ADRENORECEPTOR antagonist dexefaroxan on neurogenesis in the olfactory bulb of the adult rat in vivo: Selective protection against neuronal death |
| 001466 | M.-A. Bedard [Canada] ; F. El Massioui [France] ; C. Malapani [France] ; B. Dubois [France] ; B. Pillon [France] ; B. Renault [France] ; Yves Agid [France] | Attentional deficits in Parkinson's disease : Partial reversibility with naphtoxazine (SDZ NVI-085), a selective noradrenergic α1 agonist |
| 001602 | Un organe de contrôle inspiré de la neuromodulation pour les Réseaux à Propagation Guidée | |
| 001B55 | R. Cash ; T. Dennis ; R. L'Heureux ; R. Raisman ; F. Javoy-Agid ; B. Scatton | Parkinsons disease and dementia: norepinephrine and dopamine in locus ceruleus |
| This area was generated with Dilib version V0.6.29. |  |